Sort
48,018 grants matching “immunotherapy”
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles
$1,043,125Joe Assouline · Nanomedtrix, Llc · R44 · FY2021 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$1,042,696Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Cell Therapy Core
$1,041,313Michael I Nishimura · Loyola University Chicago · P01 · FY2012 · CA
Regulatory immune cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
$1,041,302Angus W Thomson · University Of Pittsburgh At Pittsburgh · U19 · FY2022 · AI
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
$1,040,850Timothy An-Thy Chan · Sloan-Kettering Inst Can Research · R35 · FY2018 · CA
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,040,761David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,040,761David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$1,040,760Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$1,040,760Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA
Cytokines in AIDS and Cancer Immunotherapy
$1,040,624George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Molecular Pathogenesis of Neoplasia
$1,040,298John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
LJI Epitope Validation Center: Characterization of epitope-specific T cells responding to food, fungal and inner city allergens
$1,040,067Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2019 · AI
Novel Targets for Vaccine Therapy
$1,039,362Claudia Palena · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Targeted immune therapies in heart transplantation
$1,039,260Reza Abdi · Brigham And Women'S Hospital · R35 · FY2025 · HL
Adoptive Cellular Therapies to Enhance Tolerance and Protective Immunity
$1,039,099Leslie S Kean · Emory University · U19 · FY2009 · AI
CD19-Specific Central Memory T Cell Adoptive Immunotherapy for Non-Hodgkin Lymphoma
$1,038,189Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P50 · FY2015 · CA
The role of the intestinal microbiome in cancer immunotherapy
$1,038,040Marcel R M Van Den Brink · Beckman Research Institute/City Of Hope · R35 · FY2025 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,037,336Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
SBIR: In vivo validation and IND-enabling development of MM004, a bispecific inhaled immunotherapy for RSV and MPV
$1,037,049Richard A Cone · Mucommune, Llc · R44 · FY2024 · AI
SBIR: In vivo validation and IND-enabling development of MM004, a bispecific inhaled immunotherapy for RSV and MPV
$1,036,484Richard A Cone · Mucommune, Llc · R44 · FY2023 · AI
Posttranscriptional control of gene expression
$1,036,045Barbara Felber · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Comprehensive Cancer Center Program at Fox Chase
$1,035,145Jonathan D. Chernoff · Research Inst Of Fox Chase Can Ctr · P30 · FY2021 · CA
Humanized PRO 140 for CCR5-Targeted Therapy of HIV
$1,034,766Progenics Pharmaceuticals, Inc. · R44 · FY2004 · AI
Depletion, Repopulation and Tolerance in Sensitized Recipients
$1,033,869Stuart Johnston Knechtle · Duke University · U19 · FY2019 · AI
Pediatric AIDS Clinical Trials Group
$1,033,769St. Jude Children'S Research Hospital · U01 · FY2004 · AI